NO20054319L - Neovaskulaseringspromoter - Google Patents
NeovaskulaseringspromoterInfo
- Publication number
- NO20054319L NO20054319L NO20054319A NO20054319A NO20054319L NO 20054319 L NO20054319 L NO 20054319L NO 20054319 A NO20054319 A NO 20054319A NO 20054319 A NO20054319 A NO 20054319A NO 20054319 L NO20054319 L NO 20054319L
- Authority
- NO
- Norway
- Prior art keywords
- neovaskulaseringspromoter
- neovascularization
- pharmaceutically acceptable
- acceptable salt
- active ingredient
- Prior art date
Links
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 abstract 1
- 206010029113 Neovascularisation Diseases 0.000 abstract 1
- 229960001138 acetylsalicylic acid Drugs 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003044392A JP2004262776A (ja) | 2003-02-21 | 2003-02-21 | 血管新生促進剤 |
PCT/JP2004/001700 WO2004073717A1 (fr) | 2003-02-21 | 2004-02-17 | Promoteur de la croissance de vaisseaux sanguins |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20054319D0 NO20054319D0 (no) | 2005-09-20 |
NO20054319L true NO20054319L (no) | 2005-11-18 |
Family
ID=32905451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20054319A NO20054319L (no) | 2003-02-21 | 2005-09-20 | Neovaskulaseringspromoter |
Country Status (11)
Country | Link |
---|---|
US (1) | US20060252732A1 (fr) |
EP (1) | EP1595545A4 (fr) |
JP (1) | JP2004262776A (fr) |
KR (1) | KR20050102664A (fr) |
CN (1) | CN1750832A (fr) |
AU (1) | AU2004212812A1 (fr) |
CA (1) | CA2515251A1 (fr) |
MX (1) | MXPA05008884A (fr) |
NO (1) | NO20054319L (fr) |
TW (1) | TW200418493A (fr) |
WO (1) | WO2004073717A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2999936B1 (fr) * | 2012-12-21 | 2015-01-16 | Urgo Lab | Utilisation d'acide acetylsalicylique pour la prevention et/ou le traitement des plaies du diabetique |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2307522A1 (fr) * | 1975-04-17 | 1976-11-12 | Rouillon Marie Claude | Nouvelles compositions calmantes |
JPH01503705A (ja) * | 1986-08-18 | 1989-12-14 | ビオタ・シャンティフィック・マネージメント・ピーティーワイ・リミテッド | 脈管形成の刺激および内皮化の増進 |
WO1996018298A1 (fr) * | 1994-12-14 | 1996-06-20 | Brinton Marshall K | Procede de traitement de la volaille |
NZ286082A (en) * | 1995-03-15 | 1998-09-24 | Behringwerke Ag | Method of treating acute myocardial infarction with hirudin and acetylsalicylic acid in patients not undergoing thrombolytic treatment |
ES2250983T3 (es) * | 1995-12-26 | 2006-04-16 | Teikoku Seiyaku Kabushiki Kaisha | Utilizacion del acido acetilsalicilico en la fabricacion de un medicamento para el tratamiento de las lesiones de la piel. |
JPH09255575A (ja) * | 1996-03-21 | 1997-09-30 | Green Cross Corp:The | アセチルサリチル酸誘導体含有製剤 |
JPH1112177A (ja) * | 1997-06-25 | 1999-01-19 | Teikoku Seiyaku Co Ltd | 安定なアスピリン含有外用製剤 |
DE19949252B4 (de) * | 1999-10-13 | 2004-02-12 | Lts Lohmann Therapie-Systeme Ag | Verwendung eines superfiziellen therapeutischen Systems zur topischen Applikation von Acetylsalicylsäure zur Behandlung von Akne-Erkrankungen und Verfahren zu seiner Herstellung |
ES2304989T3 (es) * | 1999-12-28 | 2008-11-01 | Teikoku Seiyaku Co., Ltd. | Agente antiprurigonoso para uso externo. |
JP2001187739A (ja) * | 1999-12-28 | 2001-07-10 | Teikoku Seiyaku Co Ltd | アレルギー性皮膚疾患治療用外用剤 |
ITMI20000261A1 (it) * | 2000-02-16 | 2001-08-16 | Zambon Group | Processo per la preparazione di piridiniliden-ftalidi |
US20030232094A1 (en) * | 2002-06-12 | 2003-12-18 | Fuller Peter E. | Composition and method for the treatment of skin irritations |
WO2005077379A1 (fr) * | 2004-02-16 | 2005-08-25 | Teikoku Seiyaku Co., Ltd. | Remede a usage externe pour lesions de la peau et des muqueuses causees par infection virale |
AU2004315561B2 (en) * | 2004-02-16 | 2010-10-28 | Teikoku Seiyaku Co., Ltd. | External preparation for treating painful skin wound |
-
2003
- 2003-02-21 JP JP2003044392A patent/JP2004262776A/ja active Pending
-
2004
- 2004-02-17 CN CNA2004800046692A patent/CN1750832A/zh active Pending
- 2004-02-17 AU AU2004212812A patent/AU2004212812A1/en not_active Abandoned
- 2004-02-17 EP EP04711734A patent/EP1595545A4/fr not_active Withdrawn
- 2004-02-17 WO PCT/JP2004/001700 patent/WO2004073717A1/fr not_active Application Discontinuation
- 2004-02-17 KR KR1020057015365A patent/KR20050102664A/ko not_active Application Discontinuation
- 2004-02-17 MX MXPA05008884A patent/MXPA05008884A/es unknown
- 2004-02-17 US US10/545,914 patent/US20060252732A1/en not_active Abandoned
- 2004-02-17 TW TW093103796A patent/TW200418493A/zh unknown
- 2004-02-17 CA CA002515251A patent/CA2515251A1/fr not_active Abandoned
-
2005
- 2005-09-20 NO NO20054319A patent/NO20054319L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20060252732A1 (en) | 2006-11-09 |
NO20054319D0 (no) | 2005-09-20 |
CA2515251A1 (fr) | 2004-09-02 |
JP2004262776A (ja) | 2004-09-24 |
TW200418493A (en) | 2004-10-01 |
AU2004212812A1 (en) | 2004-09-02 |
MXPA05008884A (es) | 2005-10-05 |
CN1750832A (zh) | 2006-03-22 |
EP1595545A1 (fr) | 2005-11-16 |
WO2004073717A1 (fr) | 2004-09-02 |
KR20050102664A (ko) | 2005-10-26 |
EP1595545A4 (fr) | 2006-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005027540D1 (de) | Feste formulierungen von ospemifen | |
NO20055631L (no) | Doseringsform inneholdende pantoprazol som aktiv ingrediens | |
NO20050060L (no) | Medikament for behandling av overaktiv blaere | |
NO20074295L (no) | Substituerte gamma lactamer som terapeutiske midler | |
SV2004001690A (es) | Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos | |
NO20080220L (no) | Formuleringer med hoy medikament belastning og doseringsformer | |
NO20052739D0 (no) | CCR5-antagonister som medikamenter | |
NO20053076D0 (no) | Farmasoytisk formulering med en uloselig aktiv forbindelse. | |
RS52169B (en) | STABLE LAKVINIMOD PREPARATIONS | |
HN2004000544A (es) | Nuevos derivados de quinolinas | |
RS54123B1 (en) | THERAPEUTIC COMBINATION CONTAINING DOLUTEGRAVIR, ABACAVIR AND LAMIVUDINE | |
BRPI0617655A2 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, ou um isômero óptico do mesmo, uso de um composto, e, formulação farmacêutica | |
ECSP055701A (es) | Nuevos derivados de pirimidinamida y el uso de los mismos | |
DK1814848T3 (da) | 2,3,4-substitueret-cyclopentanoner som terapeutiske midler | |
NO20064808L (no) | Orale matrixformuleringer med licarbazepin | |
NO20082181L (no) | Formuleringer av Fispemifen | |
AR057885A1 (es) | Acido 1-(1-(2- etoxietil) - 1- etil-7-(4- metilpiridin -2- ilamino)- 1h pirazolo (4,3-d) pirimidin -5- il) piperidina -4- carboxilico y las sales del mismo. composiciones farmaceuticas. | |
ATE537822T1 (de) | Antidepressivum | |
WO2004098577A3 (fr) | Forme posologique contenant du (s)-pantoprazole en tant qu'ingredient actif | |
NO20054319L (no) | Neovaskulaseringspromoter | |
NO20052125L (no) | Utvortes preparat for inhibering av keloiddannelse | |
DK1666473T3 (da) | Carboxylsyreforbindelser og medicinske sammensætninger indeholdende samme som aktiv ingrediens | |
NO20023111L (no) | Utvortes preparat for behandling av pruritus | |
NO20064196L (no) | Utvortes preparat for behandling av smertefulle hudskader | |
UY27910A1 (es) | Uso de un derivado de amina cíclica específico o de sus sales farmacéuticamente aceptables para tratar o prevenir la insuficiencia cardiaca |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |